SK Group is considering selling its 65% stake in Imexpharm Pharmaceutical JSC, people with knowledge of the matter said, ...
The low-cost government loan for the Blue Oval SK joint venture is the largest ever from the Advanced Technology Vehicles ...
SK Group initially bought a nearly 25% stake in Imexpharm through subsidiary SK Investment Vina III in 2020 for an undisclosed sum. Its holding rose to about 65% in 2023.
SK Group, the country's second-largest conglomerate, carried out a relatively modest year-end reshuffle Thursday, focusing ...
THE CHOSUNILBO on MSN12d
SK group announces 2025 leadership, prioritizes AI and global strategiesSK Group has unveiled its 2025 executive appointments, promoting two executives to president-level positions while enhancing ...
The Korea Times on MSN12d
SK reshuffles execs amid efforts to regroup portfolioKorea's second-largest conglomerate, SK Group, announced its end-of-year executive reshuffle and organizational restructuring ...
SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving the pharmaceutical and cell & gene therapy industries, today announced the launch of a brand ...
It comes after the holdings company acquired the cosmetics surgery clinic chain in August 2024, following its collapse in ...
Kioxia Holdings was supposed to be an irresistible debutant in a hot Japanese market, heralding the rise of a homegrown ...
SK Telecom has long been positioning itself as an AI companyEarlier this year it unveiled its AI pyramid strategyNow it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback